- Headquarters
- Paris, France · Europe
- Value chain
- Research & IP(Research & design)
- What that means
- Invents and licenses: corporate and contract research, IP and technology licensing, with little production of its own.
- Founded
- 1999
- Ownership
- Listed
- Listing
- Nasdaq:CLLS on Google Finance
- Website
- cellectis.com
- Relevance
- Moderate at its strongest, in Synthetic Biology & Genetic Engineering
Paris, FranceIn 1 capability
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Research · listed #24 of 50
Gene-editing pioneer using TALEN technology for allogeneic CAR-T cells; also listed on Euronext Growth Paris (ALCLS).
Relevance: TALEN gene-editing pioneer